[Federal Register Volume 69, Number 161 (Friday, August 20, 2004)]
[Notices]
[Pages 51682-51683]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-19130]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the meeting of 
the President's Cancer Panel.
    The meeting will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contact Person 
listed below in advance of the meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in section 552b(c)(9)(B), Title 5 U.S.C., as 
amended because the premature disclosure of information and the 
discussions would be likely to significantly frustrate implementation 
of recommendations.

    Name of Committee: President's Cancer Panel.
    Date: August 30-31, 2004.
    Open: August 30, 2004, 8 a.m. to 4 p.m.
    Agenda: Translating Research into Clinical Practice.
    Place: Grand Hyatt San Francisco, 345 Stockton Street, San 
Francisco, CA 94108.
    Closed: August 31, 2004, 9 a.m. to 12 p.m.
    Agenda: To review and evaluate prepublication manuscripts on 
Translating Research into Clinical Practices.
    Place: Grand Hyatt San Francisco, 345 Stockton Street, San 
Francisco, CA 94108.
    Contact Person: Maureen O. Wilson, PhD, Executive Secretary, 
National Cancer Institute, National Institutes of Health, 31 Center 
Drive, Building 31, Room 3A18, Bethesda, MD 20892, (301) 496-1148.
    This notice is being published less than 15 days prior to the 
meeting due to scheduling conflicts.
    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and, when applicable, the business or professional 
affiliation of the interested person.
    Information is also available on the Institute's/Center's home 
page: deainfo.nci.nih.gov/advisory/pcp/pcp.htm, where an agenda and 
any additional information for the meeting will be posted when 
available.


[[Page 51683]]


(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: August 10, 2004.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 04-19130 Filed 8-19-04; 8:45 am]
BILLING CODE 4140-01-M